AGIO insider trading
Open-market stock trades by Agios Pharmaceuticals (AGIO) executives and directors: who bought or sold, how many shares, at what price and when.
AGIO insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 26, 2026 | Gheuens Sarah | Chief Medical Officer | Sell | 7,866 | $37.69 | $296.47K |
| Oct 21, 2026 | Gheuens Sarah | Chief Medical Officer | Sell | 1,489 | $37.53 | $55.88K |
| Oct 22, 2026 | Gheuens Sarah | Chief Medical Officer | Sell | 500 | $37.52 | $18.76K |
| Aug 4, 2026 | Gheuens Sarah | Chief Medical Officer | Sell | 30,000 | $30.48 | $914.40K |
| Jul 1, 2026 | Gheuens Sarah | Chief Medical Officer | Sell | 4,007 | $37.56 | $150.50K |
| Apr 2, 2026 | Burns James William | Chief Legal Officer | Sell | 3,280 | $34.71 | $113.85K |
| Apr 2, 2026 | Gheuens Sarah | Chief Medical Officer | Sell | 2,940 | $34.71 | $102.05K |
| Apr 2, 2026 | Jones Cecilia | Chief Financial Officer | Sell | 3,141 | $34.71 | $109.02K |
| Apr 2, 2026 | Milanova Tsveta | Chief Commercial Officer | Sell | 3,262 | $34.71 | $113.22K |
| Apr 2, 2026 | Viswanadhan Krishnan | Chief Corp Dev & Strategy | Sell | 2,959 | $34.71 | $102.71K |
| Apr 2, 2026 | Goff Brian | Chief Executive Officer | Sell | 6,596 | $34.71 | $228.95K |
| Apr 2, 2026 | Goff Brian | Chief Executive Officer | Sell | 12,472 | $34.71 | $432.90K |
| Mar 5, 2026 | Viswanadhan Krishnan | Chief Corp Dev & Strategy | Sell | 2,959 | $27.80 | $82.26K |
| Mar 3, 2026 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 5,272 | $28.88 | $152.26K |
| Mar 2, 2026 | Goff Brian | Chief Executive Officer | Sell | 5,918 | $28.96 | $171.39K |
| Mar 2, 2026 | Goff Brian | Chief Executive Officer | Sell | 8,267 | $28.96 | $239.41K |
| Mar 2, 2026 | Goff Brian | Chief Executive Officer | Sell | 3,870 | $28.96 | $112.08K |
- AGIO insiders bought $0.00 and sold $3.40M in open-market trades over their last 17 filings.
Updated 2026-11-03 00:03 UTC